|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
102,230,000 |
Market
Cap: |
10.87(M) |
Last
Volume: |
10,264,973 |
Avg
Vol: |
10,236,721 |
52
Week Range: |
$0.1063 - $1.64 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Seelos Therapeutics is a clinical-stage biopharmaceutical company focused on the development of products that address unmet needs in Central Nervous System disorders and other disorders. Co.'s primary programs are SLS-002 for the potential treatment of Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder and SLS-005 for the potential treatment of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia. Co. is also developing several preclinical programs, including SLS-004, SLS-006, and SLS-007 for the potential treatment of Parkinson's Disease, SLS-010 in narcolepsy and related disorders, and SLS-012, an injectable therapy for post-operative pain management.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
158,757 |
158,757 |
209,757 |
Total Buy Value |
$0 |
$200,222 |
$200,222 |
$230,976 |
Total People Bought |
0 |
2 |
2 |
4 |
Total Buy Transactions |
0 |
2 |
2 |
4 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Damaj Bassam |
Chief Executive OfficerOfficer |
|
2009-12-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
921,361 |
|
- |
|
Wade Martin R III |
Director |
|
2009-10-06 |
4 |
A |
$1.47 |
$15,741 |
D/D |
10,708 |
191,290 |
|
- |
|
Berman Richard J |
Director |
|
2009-10-06 |
4 |
A |
$1.47 |
$30,195 |
D/D |
20,541 |
369,034 |
|
- |
|
Emil Arthur D |
Director |
|
2009-10-06 |
4 |
A |
$1.47 |
$15,741 |
D/D |
10,708 |
323,579 |
|
- |
|
Tierney David S |
Director |
|
2009-10-06 |
4 |
A |
$1.47 |
$15,741 |
D/D |
10,708 |
267,948 |
|
- |
|
Oppenheim Leonard A |
Director |
|
2009-10-06 |
4 |
A |
$1.47 |
$15,741 |
D/D |
10,708 |
362,851 |
|
- |
|
May Jacob |
owns more than 5% of security |
|
2009-07-08 |
4 |
S |
$0.24 |
$629,016 |
D/D |
(2,620,900) |
5,714,630 |
|
- |
|
May Jacob |
owns more than 5% of security |
|
2009-07-07 |
4 |
S |
$0.17 |
$256,200 |
D/D |
(1,500,000) |
8,335,530 |
|
- |
|
Oppenheim Leonard A |
Director |
|
2009-06-09 |
4 |
A |
$1.47 |
$15,741 |
D/D |
10,708 |
352,143 |
|
- |
|
Wade Martin R III |
Director |
|
2009-06-09 |
4 |
A |
$1.47 |
$15,741 |
D/D |
10,708 |
180,582 |
|
- |
|
Berman Richard J |
Director |
|
2009-06-09 |
4 |
A |
$1.47 |
$30,195 |
D/D |
20,541 |
348,493 |
|
- |
|
Tierney David S |
Director |
|
2009-06-09 |
4 |
A |
$1.47 |
$15,741 |
D/D |
10,708 |
257,240 |
|
- |
|
Emil Arthur D |
Director |
|
2009-06-09 |
4 |
A |
$1.47 |
$15,741 |
D/D |
10,708 |
312,871 |
|
- |
|
Tierney David S |
Director |
|
2009-02-09 |
4 |
A |
$1.47 |
$31,482 |
D/D |
21,416 |
246,532 |
|
- |
|
Emil Arthur D |
Director |
|
2009-02-09 |
4 |
A |
$1.47 |
$31,482 |
D/D |
21,416 |
302,163 |
|
- |
|
Oppenheim Leonard A |
Director |
|
2009-02-09 |
4 |
A |
$1.47 |
$31,482 |
D/D |
21,416 |
341,435 |
|
- |
|
Berman Richard J |
Director |
|
2009-02-09 |
4 |
A |
$1.47 |
$60,386 |
D/D |
41,079 |
327,952 |
|
- |
|
Wade Martin R III |
Director |
|
2009-02-09 |
4 |
A |
$1.47 |
$31,482 |
D/D |
21,416 |
169,874 |
|
- |
|
May Jacob |
owns more than 5% of security |
|
2009-02-05 |
4 |
B |
$0.13 |
$6,600 |
D/D |
50,000 |
9,835,530 |
2.44 |
- |
|
May Jacob |
owns more than 5% of security |
|
2009-02-04 |
4 |
B |
$0.14 |
$11,003 |
D/D |
81,501 |
9,785,530 |
2.44 |
- |
|
May Jacob |
owns more than 5% of security |
|
2009-02-03 |
4 |
B |
$0.14 |
$71,477 |
D/D |
478,862 |
9,704,029 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-12-17 |
4 |
B |
$0.80 |
$22,862 |
D/D |
28,100 |
9,225,166 |
2.44 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-12-10 |
4 |
B |
$0.06 |
$2,950 |
D/D |
50,000 |
9,197,066 |
2.36 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-11-26 |
4 |
B |
$0.08 |
$1,500 |
D/D |
20,000 |
8,350,550 |
2.36 |
- |
|
May Jacob |
owns over 5% of securities |
|
2008-11-21 |
4 |
B |
$0.07 |
$5,869 |
D/D |
84,900 |
8,400,550 |
2.44 |
- |
|
395 Records found
|
|
Page 8 of 16 |
|
|